Tech Company Financing Transactions

Precirix Funding Round

Forbion Capital Partners, INKEF Capital and JEITO participated in a $87.9 million Series B funding round for Precirix. This venture round was announced by the company on 3/24/2022.

Transaction Overview

Company Name
Announced On
3/24/2022
Transaction Type
Venture Equity
Amount
$87,900,000
Round
Series B
Investors

Forbion Capital Partners (Lead Investor) (Jasper Bos)

INKEF Capital (Lead Investor) (Simone Botti)

JEITO (Lead Investor) (Sabine Dandiguian)

BioMed Ventures

GIMV (Karl Naegler)

Healthcap Venture Capital (Mårten Steen)

Novo Ventures (Morten Døssing)

Pontifax Fund (Ohad Hammer)

V-Bio Ventures (Christina Takke)

Proceeds Purpose
The investment will allow Precirix to accelerate its growth trajectory and to further validate and broaden the technology platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Burgemeester Etienne Demunterlaan 1
Brussels, B-1090
Belgium
Email Address
Overview
PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments.
Profile
Precirix LinkedIn Company Profile
Social Media
Precirix Company Twitter Account
Company News
Precirix News
Facebook
Precirix on Facebook
YouTube
Precirix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ruth Devenyns
  Ruth Devenyns LinkedIn Profile  Ruth Devenyns Twitter Account  Ruth Devenyns News  Ruth Devenyns on Facebook
Chief Scientific Officer
Tony Lahoutte
  Tony Lahoutte LinkedIn Profile  Tony Lahoutte Twitter Account  Tony Lahoutte News  Tony Lahoutte on Facebook
Chief Technical Officer
Niva Almaula
  Niva Almaula LinkedIn Profile  Niva Almaula Twitter Account  Niva Almaula News  Niva Almaula on Facebook
VP - Bus. Development
Niva Almaula
  Niva Almaula LinkedIn Profile  Niva Almaula Twitter Account  Niva Almaula News  Niva Almaula on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/24/2022: Triple Whale venture capital transaction
Next: 3/24/2022: DataShapes venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary